Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Epilepsia. 2018 Dec 21;60(1):74–84. doi: 10.1111/epi.14621

Table 1:

Patient information

Patient Age/ Gender Implant/#electrodes FBTCS type SOZ IPA (s) Gamma % channels
1 20/M LFT/84 1,1 LT 44,45 100,100
2 50/M BFT/32 1,3 RF(1) RFT(1) 100,60 100,100
3 19/F RH/126 3,1b RO 27,66b 52,8b
4 30/F LH/121 3,3 LFT 20,28 68,24
5 25/M LFT/56 3 LT 49 79
6 22/M RFTP/102 3b,3,3b RF 10b,40,15b 3b,59,2b
7 20/F LP/48 3 LP 4 57
8 23/M BFTCa/126 3,1,1 RT(2) LT(1) 45,40,51 100,100,100
9 30/F LFTa/110 3,1 LF 34,33 100,100
10 25/M LT/RFTa/126 3,3 RT 42,20 66,79
11 37/M RTPO/78 1 RT 49 69
12 32/F LFT/84 1b LT 48b 93b
13a 34/M LT/50 1,2 LT 27,0d 93, no IPA
13b 35/M LT/72 2 LT 2 100
14 37/M RFT/128 1,2b RF 34,0b 98, no IPAb
15 16/M RH/70 3,3,3 RT 8,0,0 c, no IPA, no IPA
16 22/F LH/110 2 LT 0d no IPA

FBTCS=focal to bilateral tonic-clonic seizure, SOZ=seizure onset zone, IPA=intracranial postictal attenuation, L=left, R=right, B=bilateral, F=frontal, T=temporal, C=central, P=parietal, O=occipital, H=hemispheric

a

=stereo EEG implant

b

=provoked seizure

c

=excluded from analysis due to preictal baseline EEG <5 minutes

d

=partial postictal attenuation